Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
48 participants
INTERVENTIONAL
2011-12-06
2015-09-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Novel, Comprehensive Approach to Post-stroke Gait Rehabilitation
NCT04411303
Optimizing Gait Symmetry After Stroke Using Mechanical Constraints and Sensory Feedback
NCT07087769
Biofeedback Gait Training by Target Biomechanical Parameters in the Early Recovery Period of Stroke
NCT06299943
A Novel Mechanics-based Intervention to Improve Post-stroke Stability
NCT02964039
Effectiveness of Paretic Lower Limb Loading During Over-ground Training Among Stroke Survivors
NCT05097391
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The traditional gait training group will receive gait training as presently performed without additional modalities. The BWS group will received BWS gait training in lieu of traditional gait training. Participants will be treated in in-patient rehabilitation for a duration as determined by the clinical team; thus, the overall duration of care may be variable between participants. Time spent in gait training activities for both groups will be tracked by both service unit and by time (minutes).
Within 48 hours of discharge from the acute care facility, the participant will be transported to a separate site for kinematic gait analysis using a marker based motion capture system.
The procedure for gait analysis is as follows:
1. Investigators will place reflective markers on the following areas using non-latex adhesive tape: top of the shoulders, bony part of the pelvis on the front and back, hips, front of the thighs, outside of the knees, front of the shins, outside of the ankles, first and fifth toes, and back of each heel.
2. The participant will walk across the room in the gait analysis lab no more than 20 times at his/her choice of pace while the camera system records gait parameters and kinematics. He/she will be allowed to rest as needed during the data collection.
3. The reflective markers and adhesive tape will be removed and the participant thanked for his/her participation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Traditional Gait Training
The Traditional Gait Training group will receive gait training as presently performed without additional modalities.
Traditional Gait Training
Body Weight Support Training
The Body Weight Support group will received body weight support gait training in lieu of traditional gait training.
Body Weight Support Gait Training
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Body Weight Support Gait Training
Traditional Gait Training
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Unilateral CVA affecting at least the lower limb, and
* Medically stable as determined by the rehabilitation physician.
Exclusion Criteria
* Any lower extremity pathology on the affected side other than the effects of the CVA.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Florida Gulf Coast University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Derek J Lura, PhD
Role: PRINCIPAL_INVESTIGATOR
Florida Gulf Coast University
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2011-40
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.